Cooper Companies Inc COO

NASDAQ US Health Care

$72.32 ▼ -0.45% ($-0.33)

Index member: S&P 500

Open $71.95

Prev Close $72.65

Day Range $71.15 – $72.51

52W Range $58.89 – $89.83

Market Cap $14.17B

P/E (TTM) 59.82

Beta 0.82

Div Yield 0.02%

EPS (TTM) $1.18

📋 Company Profile

Industry	Health Care
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
Currency	USD
IPO Date	1983-01-21
Shares Out.	195,030,000
Website	coopercos.com/ ↗
Phone	13026365400
Employees	15,000
Revenue	$1.08B
Gross Profit	$735.4M
Net Income	-$77.9M
Free Cash Flow	$569.5M
Total Assets	$12.48B
Total Liabilities	$4.24B
Equity	$8.24B

About Cooper Companies Inc

CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.

Cooper Companies Inc is a publicly traded company under the ticker symbol COO on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.